Interventions to increase HPV vaccination coverage: A systematic review

References

• Satterwhite CL, Torrone E, Meites E, Dunne EF, Mahajan R, Ocfemia MC, Su J, Xu F, Winstock H. Sexually transmitted infections among US women and men: prevalence and incidence estimates 2008. Sex Transm Dis 2013; 40(3):187-93; PMID:23403598
   PubMed Web of Science ®Google Scholar
• Saraiya M, Unger ER, Thompson TD, Lynch CF, Hernandez BY, Lyu CW, Steinau M, Watson M, Wilkinson EJ, Hopenhayn C, et al. US assessment of HPV types in cancer: implications for current and 9-valent HPV vaccines. J Natl Cancer I 2015; 107(6):djv086
   PubMedGoogle Scholar
• Markowitz LE, Dunne EF, Saraiya M, Chesson H, Curtis CR, Gee J, Bocchini JA, Unger ER. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report (MMWR) 2014; 63(RR05):1-30
   PubMed Web of Science ®Google Scholar
• Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices. Morbidity and Mortality Weekly Report (MMWR) 2007; 56(RR02):1-24
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices. Morbidity and Mortality Weekly Report (MMWR) 2010; 59(20):626-9
   PubMedGoogle Scholar
• Petrosky E, Bocchini JA, Hariri S, Chesson H, Curtis CR, Saraiya M, Unger ER, Markowitz LE. Use of 9-Valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the Advisory Committee on Immunization Practices. Morbidity and Mortality Weekly Report (MMWR) 2015; 64(11):300-4
   PubMed Web of Science ®Google Scholar
• Lacey CJN, Lowndes CM, Shah KV. Chapter 4: burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine 2006; 24(Suppl 3):S3/34-41
   Google Scholar
• Schiller JT, Castellsague X, Garland SM. A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine 2012; 30(Suppl 5):F123-38; PMID:23199956
   PubMed Web of Science ®Google Scholar
• Markowitz LE, Hariri S, Lin C, Dunne EF, Steinau M, McQuillan G, Unger ER. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003–2010. J Infect Dis 2013; 208:385-93; PMID:23785124
   PubMed Web of Science ®Google Scholar
• Leval A, Herweijer E, Arnheim-Dahlstrom L, Walum H, Frans E, Sparén P, Simard JF. Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability. J Infect Dis 2012; 206(6):860-6; PMID:22815381
   PubMed Web of Science ®Google Scholar
• Read TR, Hocking JS, Chen MY, Donovan B, Bradshaw CS, Fairley CK. The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme. Sex Transm Infect 2011; 87:544-7; PMID:21970896
   PubMed Web of Science ®Google Scholar
• Brotherton JM, Fridman M, May CL, Chappell G, Saville AM, Gertig DM. Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet 2011; 377(9783):2085-92; PMID:21684381
   PubMed Web of Science ®Google Scholar
• Powell SE, Hariri S, Steinau M, Bauer HM, Bennett NM, Bloch KC, Niccolai LM, Schaffer S, Unger ER, Markowitz LE. Impact of human papillomavirus (HPV) vaccination on HPV 16/18-related prevalence in precancerous cervical lesions. Vaccine 2012; 31(1):109-13; PMID:23137842
   PubMed Web of Science ®Google Scholar
• Reagan-Steiner S, Yankey D, Jeyarajah J, Elam-Evans-LD, Singleton JA, Curtis CR, MacNeil J, Markowitz LE, Stokley S. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years: United States, 2014. Morbidity and Mortality Weekly Report (MMWR). 2015; 64(29):784-92
   PubMed Web of Science ®Google Scholar
• Healthy People 2020 objectives: immunization and infectious diseases. Available at https://www.healthypeople.gov/2020/topics-objectives/topic/immunization-and-infectious-diseases/objectives. Accessed May 30, 2015
   Google Scholar
• President's Cancer Panel. Accelerating HPV vaccine uptake: urgency for action to prevent cancer. A report to the President of the United States from the President's Cancer Panel. Bethesda, MD: National Cancer Institute. 2014. Available at http://deainfo.nci.nih.gov/advisory/pcp/annualReports/HPV/index.htm. Accessed May 30, 2015
   Google Scholar
• Fu L, Bonhomme L, Cooper S, Joseph J, Zimet G. Educational interventions to increase HPV vaccination acceptance: a systematic review. Vaccine 2014; 32:1901-20; PMID:24530401
   PubMed Web of Science ®Google Scholar
• Brewer N, Fazekas K. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med 2007; 45:107-14; PMID:17628649
   PubMed Web of Science ®Google Scholar
• Gamble H, Klosky J, Parra G, Randolph M. Factors influencing familial decision-making regarding human papillomavirus vaccination. J Pediatr Psych 2010; 35(7):704-15; http://dx.doi.org/10.1093/jpepsy/jsp108
   PubMed Web of Science ®Google Scholar
• Holman D, Bernard V, Roland K, Watson M, Liddon N, Stokley S. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr 2014; 168(1):76-82; PMID:24276343; http://dx.doi.org/10.1001/jamapediatrics.2013.2752
   PubMed Web of Science ®Google Scholar
• Walhart T. Parents, adolescents, children and the human papillomavirus vaccine: a review. Int Nurs Rev 2012; 59:305-11; PMID:22897180; http://dx.doi.org/10.1111/j.1466-7657.2012.00991.x
   PubMed Web of Science ®Google Scholar
• Niccolai L, Hansen C. Practice- and community-based interventions to increase human papillomavirus vaccine coverage: a systematic review. JAMA Pediatr 2015; 169(7):686-92; PMID:26010507; http://dx.doi.org/10.1001/jamapediatrics.2015.0310
   PubMed Web of Science ®Google Scholar
• Community Preventive Services Task Force. The guide to community preventive services: increasing appropriate vaccination. Available at |www.thecommunityguide.org/vaccines/index.html. Last updated: February 13, 2015. Accessed May 30, 2015
   Google Scholar
• Community Preventive Services Task Force. What is the Community Guide? Available at www.thecommunityguide.org/about/index.html. Last updated: April 6, 2015. Accessed October 26, 2015
   Google Scholar
• Bugenske E, Stokley S, Kennedy A, Dorell C. Middle school vaccination requirements and adolescent vaccination coverage. Pediatrics 2012; 129:1056-63; PMID:22566425; http://dx.doi.org/10.1542/peds.2011-2641
   PubMed Web of Science ®Google Scholar
• Dempsey A, Schaffer S. Human papillomavirus vaccination rates and state mandates for tetanus-containing vaccines. Prev Med 2011; 52(3–4):268-9; PMID:21195727
   PubMed Web of Science ®Google Scholar
• Potter R, DeVita S, Vranesich P, Boulton M. Adolescent immunization coverage and implementation of new school requirements in Michigan, 2010. Am J Public Health 2014; 104(8):1526-33; PMID:24922144; http://dx.doi.org/10.2105/AJPH.2014.301910
   PubMed Web of Science ®Google Scholar
• Chao C, Preciado M, Slezak J, Xu L. A randomized intervention of reminder letter for human papillomavirus vaccine series completion. J Adolescent Health 2015; 56:85-90; http://dx.doi.org/10.1016/j.jadohealth.2014.08.014
   PubMed Web of Science ®Google Scholar
• Kharbanda E, Stockwell M, Fox H, Andres R, Lara M, Rickert V. Text message reminders to promote human papillomavirus vaccination. Vaccine 2011; 29:2537-41; PMID:21300094; http://dx.doi.org/10.1016/j.vaccine.2011.01.065
   PubMed Web of Science ®Google Scholar
• Patel A, Stern L, Unger Z, Debevec E, Roston A, Hanover R, Morfesis J. Staying on track: a cluster randomized controlled trial of automated reminders aimed at increasing human papillomavirus vaccine completion. Vaccine 2014; 32: 2428-33; PMID:24631099; http://dx.doi.org/10.1016/j.vaccine.2014.02.095
   PubMed Web of Science ®Google Scholar
• Suh CA, Saville A, Daley MF, Glazner JE, Barrow J, Stokley S, Dong F, Beaty B, Dickinson LM, Kempe A. Effectiveness and net cost of reminder/recall for adolescent immunizations. Pediatrics 2012; 129(6):1437-45; http://dx.doi.org/10.1542/peds.2011-1714
   PubMed Web of Science ®Google Scholar
• Szilagyi PG, Albertin C, Humiston SG, Rand CM, Schaffer S, Brill H, Stankaitis J, Yoo, BK, Blumkin AK, Stokley S. A randomized trial of the effect of centralized reminder/recall on immunizations and preventive care visits for adolescents. Acad Pediatr 2013; 13(3):204-13; PMID:23510607; http://dx.doi.org/10.1016/j.acap.2013.01.002
   PubMed Web of Science ®Google Scholar
• Bar-Shain D, Stager M, Runkle A, Leon J, Kaelber D. Direct messaging to parents/guardians to improve adolescent immunizations. J Adolescent Health 2015; 56:S21-26; http://dx.doi.org/10.1016/j.jadohealth.2014.11.023
   PubMed Web of Science ®Google Scholar
• Morris J, Wang W, Wang L, Peddecord KM, Sawyer M. Comparison of reminder methods in selected adolescents with records in an immunization registry. J Adolescent Health 2015; 56:S27-32; http://dx.doi.org/10.1016/j.jadohealth.2015.01.010
   Google Scholar
• Rand CM, Brill H, Albertin C, Humiston SG, Schaffer S, Shone LP, Blumkin AK, Szilagyi PG. Effectiveness of centralized text message reminders on human papillomavirus coverage for publicly insured adolescents. J Adolescent Health 2015; 56:S17-20; http://dx.doi.org/10.1016/j.jadohealth.2014.10.273
   PubMed Web of Science ®Google Scholar
• Hopfer S. Effects of a narrative HPV vaccine intervention aimed at reaching college women: a randomized controlled trial. Prev Sci 2012; 13:173-82; PMID:21993613; http://dx.doi.org/10.1007/s11121-011-0254-1
   PubMed Web of Science ®Google Scholar
• Vanderpool RC, Cohen EL, Crosby RA, Jones MG, Bates, W, Casey BR, Collins T. “1-2-3 Pap” intervention improves HPV vaccine series completion among Appalachian women. J Commun 2013; 63:95-115; PMID:26560123; http://dx.doi.org/10.1111/jcom.12001
   PubMed Web of Science ®Google Scholar
• Kempe A, Barrow J, Stokley S, Saville A, Glazner JE, Suh C, Federico S, Abrams L, Seewald L, Beaty B, et al. Effectiveness and cost of immunization recall at school-based health centers. Pediatrics 2012; 129:1446-52; http://dx.doi.org/10.1542/peds.2011-2921
   PubMed Web of Science ®Google Scholar
• Patel D, Zochowski M, Peterman S, Dempsey A, Ernst S, Dalton V. Human papillomavirus vaccine intent and uptake among female college students. J Am Coll Health 2012; 60(2):151-61; PMID:22316412; http://dx.doi.org/10.1080/07448481.2011.580028
   PubMed Web of Science ®Google Scholar
• Cates J, Shafer A, Diehl S, Deal A. Evaluating a county-sponsored social marketing campaign to increase mothers' initiation of HPV vaccine for their pre-teen daughters in a primary rural area. Soc Mar Q 2011; 17(1):4-26; PMID:21804767; http://dx.doi.org/10.1080/15245004.2010.546943
   PubMedGoogle Scholar
• Cates J, Diehl S, Crandell J, Coyne-Beasley T. Intervention effects from a social marketing campaign to promote HPV vaccination in preteen boys. Vaccine 2014; 32:4171-8; PMID:24886960; http://dx.doi.org/10.1016/j.vaccine.2014.05.044
   PubMed Web of Science ®Google Scholar
• Szilagyi PG, Humiston SG, Gallivan S, Albertin C, Sandler M, Blumkin AK. Effectiveness of a citywide patient immunization navigator program on improving adolescent immunizations and preventive care visit rates. Arch Pediatr Adol Med 2011; 165(6):547-53; http://dx.doi.org/10.1001/archpediatrics.2011.73
   PubMed Web of Science ®Google Scholar
• Rickert V, Auslander B, Cox D, Rosenthal S, Rupp R, Zimet G. School-based HPV immunization of young adolescents: effects of two brief health interventions. Hum Vaccin Immunother 2015; 11(2):315-21; PMID:25692717; http://dx.doi.org/10.1080/21645515.2014.1004022
   PubMed Web of Science ®Google Scholar
• Ruffin MT, Plegue MA, Rockwell PG, Young AP, Patel DA, Yeazel MW. Impact of an electronic health record (EHR) reminder on human papillomavirus (HPV) vaccine initiation and timely completion. J Am Board Fam Med 2015; 28(3):324-33; PMID:25957365; http://dx.doi.org/10.3122/jabfm.2015.03.140082
   PubMed Web of Science ®Google Scholar
• Szilagyi PG, Serwint JR, Humiston SG, Rand CM, Schaffer S, Vincelli P, Dhepyasuwan N, Blumkin A, Albertin C, Curtis CR. Effect of provider prompts on adolescent immunization rates: a randomized trial. Acad Pediatr 2015; 15:149-57; PMID:25748976; http://dx.doi.org/10.1016/j.acap.2014.10.006
   PubMed Web of Science ®Google Scholar
• Gilkey MB, Dayton AM, Moss JL, Sparks AC, Grimshaw AH, Bowling JM, Brewer NT. Increasing provision of adolescent vaccines in primary care: a randomized controlled trial. Pediatrics 2014; 134:346-53; http://dx.doi.org/10.1542/peds.2013-4257
   PubMed Web of Science ®Google Scholar
• Cassidy B, Braxter B, Charron-Prochownik D, Schlenk E. A quality improvement initiative to increase HPV vaccine rates using an educational and reminder strategy with parents of preteen girls. J Pediatr Health Care 2014; 28(2):155-64; PMID:23522561; http://dx.doi.org/10.1016/j.pedhc.2013.01.002
   PubMed Web of Science ®Google Scholar
• Fiks AG, Grundmeier RW, Mayne S, Song L, Feemster K, Karavite D, Hughes CC, Massey J, Keren R, Bell LM, et al. Effectiveness of decision support for families, clinicians, or both on HPV vaccine receipt. Pediatrics 2013; 131:1114-24; PMID:23650297; http://dx.doi.org/10.1542/peds.2012-3122
   PubMed Web of Science ®Google Scholar
• Matheson EC, Derouin A, Gagliano M, Thompson JA, Blood-Siegfried J. Increasing HPV vaccination series completion rates via text message reminders. J Pediatr Health Care 2014; 28(4):35-9; PMID:23195652; http://dx.doi.org/10.1016/j.pedhc.2013.09.001
   PubMed Web of Science ®Google Scholar
• Moss JM, Reiter P, Dayton, A, Brewer NT. Increasing adolescent immunization by webinar: a brief provider intervention at federally qualified health centers. Vaccine 2012; 30:4960-3; PMID:22652406; http://dx.doi.org/10.1016/j.vaccine.2012.05.042
   PubMed Web of Science ®Google Scholar
• Perkins R, Zisblatt L, Legler A, Trucks E, Hanchate A, Sheinfeld Gorin S. Effectiveness of a provider-focused intervention to improve HPV vaccination rates in boys and girls. Vaccine 2015; 33:1223-9; PMID:25448095; http://dx.doi.org/10.1016/j.vaccine.2014.11.021
   PubMed Web of Science ®Google Scholar
• Pahud B, Clard S, Herigon JC, Sherman A, Lynch DA, Hoffman A, Jackson MA. A pilot program to improve vaccination status for hospitalized children. Hosp Pediatr 2015; 5(1):35-41; PMID:25554757; http://dx.doi.org/10.1542/hpeds.2014-0027
   PubMedGoogle Scholar
• Chung R, Walter E, Kemper A, Dayton A. Keen on teen vaccines: improvement of adolescent vaccine coverage in rural North Carolina. J Adolescent Health 2015; 56:S14-16; http://dx.doi.org/10.1016/j.jadohealth.2014.10.272
   Google Scholar
• Staras S, Vadaparampil S, Livingston M, Thompson L, Sanders A, Shenkmen E. Increasing human papillomavirus vaccine initiation among publicly insured Florida adolescents. J Adolescent Health 2015; 56:S40-46; http://dx.doi.org/10.1016/j.jadohealth.2014.11.024
   Google Scholar
• Bundy DG, Persing NM, Solomon BS, King TM, Murakami P, Thompson RE, Engineer LD, Lehmann CU, Miller MR. The ImmProve Project: Leveraging electronic health record data to promote immunization delivery. Acad Pediatr 2013; 13(5):458-65; PMID:23726754http://dx.doi.org/10.1016/j.acap.2013.03.004
   PubMed Web of Science ®Google Scholar
• Daley MF, Kempe A, Pyrzanowski J, Vogt TM, Dickinson LM, Kile D, Fang H, Rinehart DJ, Shlay JC. School-located vaccination of adolescents with insurance billing: cost, reimbursement, and vaccination outcomes. J Adolescent Health 2014; 54:282-8; http://dx.doi.org/10.1016/j.jadohealth.2013.12.011
   PubMed Web of Science ®Google Scholar
• Stubbs B, Panozzo C, Moss J, Reiter P, Whitesell D, Brewer N. Evaluation of an intervention providing HPV vaccine in schools. Am J Health Behav 2014; 38(1):92-102; PMID:24034684; http://dx.doi.org/10.5993/AJHB.38.1.10
   PubMed Web of Science ®Google Scholar
• Harper DM, Verdenius I, Harris GD, Barnett AL, Rosemergey BE, Arey AM, Wall J, Malnar GJ. The influence of free quadrivalent human papillomavirus vaccine (HPV4) on the timely completion of the three dose series. Prev Med 2014; 61:20-5; PMID:24440159; http://dx.doi.org/10.1016/j.ypmed.2014.01.007
   PubMed Web of Science ®Google Scholar
• Chesson H, Ekwueme D, Saraiya M, Watson M, Lowy D, Markowitz LE. Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States. Vaccine 2012; 30(42):6016-9; PMID:22867718; http://dx.doi.org/10.1016/j.vaccine.2012.07.056
   PubMed Web of Science ®Google Scholar
• Rosenthal S, Weiss T, Zimet G, Ma L, Good M, Vichnin M. Predictors of HPV vaccine uptake among women aged 19–26: importance of a physician's recommendation. Vaccine 2011; 29(5):890-895; PMID:20056186; http://dx.doi.org/10.1016/j.vaccine.2009.12.063
   PubMed Web of Science ®Google Scholar
• Hofstetter A, Rosenthal S. Health care professional communication about STI vaccines with adolescents and parents. Vaccine 2014; 32(14):1616-23; PMID:23791695; http://dx.doi.org/10.1016/j.vaccine.2013.06.035
   PubMed Web of Science ®Google Scholar
• Hofstetter A, Rosenthal S. Factors impacting HPV vaccination: lessons for health care professionals. Exp Rev Vaccines 2014; 13(8):1013-26; http://dx.doi.org/10.1586/14760584.2014.933076
   PubMed Web of Science ®Google Scholar